Lv51
840 积分 2025-06-06 加入
Anti-CD19 CAR T cell therapy for refractory SLE-ITP
2个月前
已完结
Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities - a Multicenter Retrospective Analysis
2个月前
已关闭
Novel strategies to manage CAR-T cell toxicity
2个月前
已完结
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
3个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
3个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
4个月前
已完结
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
4个月前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
4个月前
已完结
The U.S. Food and Drug Administration's Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
4个月前
已完结
Autoimmune and genetic-cholestatic liver diseases: the new guidelines
5个月前
已完结
皖公网安备34019202002308
